/ncam-2024.jpg?sfvrsn=8b796127_1)
| Morning Session | Programme |
|---|---|
| 9.00 am | Opening address Adj A/Prof Chee Cheng Ean Executive Director, NCIS |
Education Session Session Chair: Dr Yong Wei Peng | |
| 9.10 am | Advancing Precision Medicine with Artificial Intelligence: Trends and Challenges Dr Vaibhav Rajan Assistant Professor, Department of Information Systems and Analytics, School of Computing, NUS |
| 9.30 am | Harnessing the Power of AI in Cancer Imaging Dr James Hallinan Department of Diagnostic Imaging, NUH |
| 9.50 am | Big 5 in Healthcare AI Dr Nesaretnam Barr Kumarakulasinghe Department of Haematology Oncology, NCIS |
| 10.10 am | Tea Break |
Oral Abstracts Presentation – Basic Science | |
| 10.55 am | scRNA-seq reveals molecular mechanisms of refractory/relapsed (RR) acute myeloid leukemia Dr Jianbiao Zhou CSI |
| 11.10 am | Iqgap3 regulates stomach regeneration and pre-cancerous metaplasia development via Myc-pathway Dr Junichi Matsuo CSI |
| 11.25 am | Hepatocyte-macrophage interaction in hepatic inflammation triggered by ADAR1 deficiency Dr Wei Liang Gan CSI |
Oral Abstracts Presentation – Translational Science | |
| 11.40 am | Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases A/Prof Raghav Sundar Department of Haematology-Oncology, NCIS |
| 11.55 am | MACIR: A Novel Prognostic Marker and Therapeutic Target in the Immuno-Oncology Landscape of DLBCL Ms Charmaine Ong CSI |
| 12.10 pm | Coordinated changes in the tumor microenvironment (TME) are associated with increased risk of therapeutic failure in newly diagnosed diffuse large b-cell lymphoma (DLBCL) Dr Cinnie Soekojo Department of Haematology-Oncology, NCIS |
| 12.25 pm | Lunch |
| Afternoon Session | Programme |
|---|---|
| 2.00 pm | Phase I PIANO Trial - PIPAC-Oxaliplatin and Systemic Nivolumab Combination for Gastric Cancer Peritoneal Metastases: Clinical and Translational Outcomes Dr Hon Lyn Tan Department of Haematology-Oncology, NCIS |
| 2.15 pm | A phase Ib/II study of pacritinib, an interleukin 1 receptor associated kinase 1 (IRAK1) inhibitor, in patients (pts) with solid cancers (Ca) harboring 1q21.3 copy number amplification (CNA) Dr Joline Lim Department of Haematology-Oncology, NCIS |
| 2.30 pm | Phase II randomized trial of induction cisplatin and gemcitabine (GP) versus cisplatin, gemcitabine, pembrolizumab, and bevacizumab (GPPB) in nasopharyngeal cancer (NPC) Dr Victor Lee Guan Hui Department of Medical Oncology, NCIS |
| Oral Abstracts Presentation - Nursing/Paramedical/Supportive Care | |
| 2.45 pm | The interplay of healthcare policies, drug costs, and ‘time toxicities’ in biologics usage for human epidermal growth factor receptor 2 (HER2) positive breast cancer Dr Jia Li Low Department of Haematology-Oncology, NCIS |
| 3.00 pm | Management of burnout in nurses working in a haematology-oncology ward in an acute care hospital: A best practice implementation project Ms Joanna Ho Ward 56, NCIS |
| 3.15 pm | Establishing an Advanced Practice Nurse (APN)-Led Breast Cancer Survivorship Clinic at the National University Cancer Institute, Singapore (NCIS): A Year's Experience Ms Litang Chen Department of Oncology Nursing, NCIS |
| 3.30 pm | Refreshments |
| Plenary Session Session Chair: A/Prof David Tan | |
| 3.45 pm | Intelligence: the next generation of precision in oncology Dr Frank Lin Senior Research Fellow, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney |
| Hear the Journey Session Session Chair: Dr Joline Lim | |
| 4.15 pm | Unexpected Paths: The Joys of a Young Clinician-Scientist Dr Joshua Tay Consultant, Department of Otolaryngology - Head & Neck Surgery, NUH |
| 4.35 pm | Living the best of both worlds: A personal scientific journey A/Prof Su Xin Yi Executive Director, Institute of Molecular and Cell Biology (IMCB) Senior Consultant, Vitreo-retinal Surgeon, National University Hospital (NUH) Senior Consultant, Vitreo-retinal Surgeon, National University Hospital (NUH) Co-Director, Centre of Innovation and Precision Eye Health (NUS) |
| 4.55 pm | Cocktail and networking session |
| 5.30 pm | Announcement of Award Winners |
| 5.45 pm | Closing Address Prof Chng Wee Joo Group Director, NUHS Research Office Senior Consultant, Department of Haematology-Oncology, NCIS |
Webinar ID: 993 5813 9021
Passcode: 507629
| Morning Session | Programme |
|---|---|
| 9.10 am | The Clinical Frailty Scale, The Future of Geriatric Assessments in Oncology Dr Matthew Chen Zhixuan Consultant, Division of Geriatric Medicine, Department of Medicine, NUH |
| 9.40 am | Palliative Care in Geriatric Oncology Adj A/Prof Noreen Chan Senior Consultant, Division of Palliative Care, NCIS Adj Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, NUS |
| 10.00 am | Geriatric Oncology Multidisciplinary Tumor Board Discussion Moderators:
Panelists:
|
/programmes/paynow.png?sfvrsn=5c33c170_1)
/programmes/institution-billing-button.png?sfvrsn=7c7e61a_1)
For registration to the NCAM mini symposium, please click here
